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Abstract 
Proliferating neural stem cells and intermediate progenitors persist in the 
ventricular-subventricular zone (V-SVZ) of the adult mammalian brain.  This 
extensive germinal layer in the walls of the lateral ventricles is the site of birth of 
different types of interneurons destined for the olfactory bulb..  The cell cycle 
dynamics of stem cells (B1 cells), intermediate progenitors (C cells) and 
neuroblasts (A cells) in the V-SVZ, and the number of times these cells divide 
remain unknown.  Using whole mounts of the walls of the lateral ventricles of 
adult mice and three cell cycle analysis methods using thymidine analogs we 
determined the proliferation dynamics of B1, C and A cells in vivo.  Ascl1+ C cells 
were heterogeneous with a cell cycle length (TC) of 18-25 hrs and a long S phase 
(TS) of 14-17 hrs. After C cells,  Doublecortin+ A cells were, the second most 
common dividing cell type in the V-SVZ, and  had a TC of 18 hrs and TS of 9 hrs.  
hGFAP::GFP+ B1 cells had a surprisingly short TC of 17-18 hrs and a TS of 4 hrs.  
 Progenitor population analysis suggests that following the initial division of B1 
cells, C cells divide three times and A cells once, possibly twice. These data 
provide essential information on the dynamics of adult progenitor cell proliferation 
in the V-SVZ and how large numbers of new neurons continue to be produced in 
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the adult mammalian brain.   
 
Significance Statement 
The time taken by neural stem cells and intermediate progenitor cells to transit 
through the cell cycle. and data on the number of times they  divide reveals the 
lineage for the generation of new neurons in the adult rodent brain. 
\body 
Abbreviations: V-SVZ ventricular-subventricular zone, TS S phase length, TG2 G2 
phase length, TM  mitosis length, TG1 G1 phase length, TC cell cycle length, GFAP 
glial fibrillary acidic protein, Ascl1 Acheate-scute complex homologue 1, DCX 
doublecortin, pHH3 phosphohistone H3, EdU 5-ethynyl-2'-deoxyuridine, CldU 5-
chloro-2’-deoxyuridine, PLM percentage of labeled mitoses, CL cumulative 
labeling, DA double analogs. 
 
Introduction  
Neurogenesis continues along the walls of the lateral ventricle in the adult 
rodent brain. Neural stem cells correspond to a subpopulation of local astrocytes 
(B1 cells) (1), (2), (3), which retain an apical contact with the ventricle. Therefore, 
this adult germinal layer includes not only a subventricular component, but also a 
ventricular zone; i.e. ventricular-subventricular zone (V-SVZ) (4). B1 cells give 
rise to intermediate progenitors, or transit amplifying cells (C cells), which divide 
to generate neuroblasts (A cells) that continue to proliferate  (5), (6) (7)  and 
migrate tangentially along the rostral migratory stream to the olfactory bulb, a 
process of continuous neuronal replacement that occurs throughout life  (8), (9), 
(10).   
 While the lineage in the V-SVZ has been determined, the cell cycle 
dynamics of each cell population remain unknown.  An essential amplifying stage 
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within the lineage is the proliferation of C and A cells.  Small changes in the cell 
cycle length or number of times these intermediate precursors divide could result 
in significant changes in the number of neurons produced. Previous studies 
estimated cell cycle dynamics for all dividing cells, assuming a homogeneous 
population. Moreover, the calculated length of the cell cycle (TC) for all V-SVZ 
cells vary in different publications from 13-14 hrs (11) or 18-21 hrs.(12), (13), (14). 
Length of the S phase (TS) as short as 4 hrs (11) or as long as 8.5-13 hrs (12), 
(13), (14) has also been reported. These variabilities might be explained not only 
by the pooling of all proliferating V-SVZ cells, but also because these previous 
studies are based on the analysis of tissue sections.  Neuroblasts continue to 
divide as they actively migrate tangentially  (5), (15) Therefore dividing cells move 
in and out the counting bin in coronal or sagittal sections likely introducing errors 
in the analysis  (16).  
  Here, we estimated the cell cycle dynamics of V-SVZ progenitors in vivo 
(Fig. 4, 5) using multiple methods and a whole mount preparation that does not 
require sectioning (17). The spatial localization of neural stem cells determines 
the subtypes of olfactory bulb interneurons produced (18) (19); however, we 
found that the cell cycle dynamics were very similar across different subregions of 
the V-SVZ (Fig. S2G-J).  Interestingly, our results indicate that actively dividing 
neural stem cells had a surprisingly short S phase.  C cells had a much longer TS 
and their cell cycle dynamics were heterogeneous. Our data further indicate that 
in each lineage tree, C cells divided approximately three times and A cells once or 
twice.  This analysis reveals the in vivo dynamics of cell proliferation and neuronal 
production in this major adult germinal layer.  
 
Results  
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Overall Estimates of Cell Types Dividing in the Adult V-SVZ 
To label dividing cells during S phase we used thymidine analogs 5-chloro-
2’-deoxyuridine (CldU)  (20), (21) and 5-ethynyl-2'-deoxyuridine (22) which we 
found can be readily detected with similar sensitivity and without cross-reactivity 
(see suppl. mat.) However, we observed that EdU had long-term toxicity  (see 
Fig. S1B-H) and therefore used EdU only for short-term labeling experiments. 
    Three markers were used for identification of the different proliferating 
progenitors in the V-SVZ: GFAP for B1 cells, Ascl1 for C cells (23), and DCX for A 
cells (24).  Since GFAP antibodies primarily stain the processes of B1 cells, we 
used hGFAP::GFP mice  (25), (26), which express green fluorescent protein 
under the control of the human GFAP promoter (Fig. 1A, S1B-I).  In these mice, a 
small fraction (1.90+/-0.15%, n=14) of all GFP labeled cells also stained for Ascl1. 
Conversely, a small subpopulation (3.07+/-0.57%; Fig. 1D) of Ascl1+ cells were 
also positive for GFP.  This population could correspond to a transitional stage in 
the lineage  (27), (28) or to a population of long-term self-renewing neural stem 
cells that express Ascl1 (29), or both.  The expression of Ascl1 was also retained 
in a subpopulation of DCX+ cells: 15.87+/-1.64% of the Ascl1+ cells were DCX+ 
(10.67+/-3.12% of DCX+ cells were Ascl1+, n=3). 
We first determined the number of cells of the different types in the S 
phase using V-SVZ whole mounts.  Following a single injection of EdU (30’ 
survival), GFP+ cells accounted for 3.92+/-0.91%, (n=5), Ascl1+ for 40.06+/-
1.78%, (n=4); and DCX for 35.79+/-2.09% (n=3) of EdU+ cells (Fig.1D-G).  We 
next quantified the percentage of mitotic cells (identified by pHH3 staining) among 
hGFAP::GFP+, Ascl1+, and DCX+ cells.  Consistent with the EdU labeling, the 
majority of pHH3+ cells in the V-SVZ corresponded to Ascl1+ (45.89+/-0.08%, 
n=60) and DCX+ (45.57+/-2.66%; n=7) cells. hGFAP::GFP+pHH3+ were less 
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common (4.80+/-0.45%, n=20; Fig.1D,H-L). Since quantifications of proliferating 
cells based on EdU incorporation or pHH3 staining may be affected by the length 
of TS and TM  with respect to TC, we also stained whole mounts with Ki67, a 
proliferation marker that is expressed throughout most of the cell cycle except G0 
(30).  We found that for all Ki67+ cells, 54.01+/-3.22% were Ascl1+, 53.52+/-
2.54% were DCX+ and 3.30+/-0.95% were GFP+ (in hGFAP::GFP mice).  
Together, these results indicate that in the adult V-SVZ proliferating Ascl1 and 
DCX+ cells are both much more common than dividing hGFAP::GFP+ cells.  
We also counted the number of pHH3 or EdU (30’ survival) labeled Ascl1 
and hGFAP::GFP+ cells during different times of day and night (Fig. S2A-E and 
suppl. mat.). We found that the rate of proliferation for these two populations in 
the V-SVZ cells remained relatively constant with the circadian rhythm. 
 
Actively Dividing hGFAP::GFP Cells Complete the Cell Cycle in Less than a 
Day 
B1 cells: Cumulative Labeling Method (CL).  
hGFAP::GFP mice received 1 to 16 injections of EdU (one injection every 2 
hrs) and were sacrificed 30’ after the last injection. The total number of GFP+ 
cells remained constant at all survival times studied, indicating that EdU injections 
did not affect the total number of GFP+ cells within the V-SVZ (Fig. 2). 
    The labeling index (LI: the number of double labeled cells divided by the total 
number of GFP+ cells; n=5) progressively increased up to 14 hrs, reaching a 
plateau with a LI of y=0.08610.  This corresponds to the growth fraction (GF), 
indicating that 8.6% of the GFP+ population is actively proliferating (Fig. 2A-E).  
    The data (Fig. 2D) can be described by two regression lines:  “a” the linear 
increase in cell labeling between 30’ and 14 hrs (y=0.00486x+0.02186); “b” the 
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horizontal line between 14 and 24 hrs. The time (in the x axis) when the two 
regression lines intersect equals TC minus TS = 13.22 hrs.  The intersect of line 
“a” with the y axis is defined as the initial labeling index (LI0) and corresponds to 
GF x TS/TC (16) (31). For our data, LI0 was 0.022.  From these three equations we 
calculated a TC of 17.73 hrs and a TS of 4.50 hrs for GFP+ cells.  Since the 
plateau (the intersect between lines a & b) is reached when all dividing GFP+ 
cells have incorporated EdU, this method over-represents the population of 
cycling cells with the slowest TC  (32), (33).  For this reason, 17.73 hrs is likely a 
reflection of the GFP+ cells that take the longest time to complete the cell cycle. 
B1 cells: Double Thymidine Analog Method (DA).   
    We next employed the DA method  (31), (32) to determine TS for the GFP+ 
cells.  We labeled GFP+ cells in S phase with an initial injection of CldU followed 
2 hrs later by an injection of EdU and a final survival of 30’ (Fig. 2F-H; n=5; see 
control experiments for EdU and CldU specificity in suppl. mat.).  Cells labeled by 
CldU, but not EdU (GFP+CldU+EdU-) had left S phase.  The ratio of 
GFP+CldU+EdU- cells over the total number of cells in the S phase (GFP+EdU+) 
equals 2 hrs/TS. This ratio for each animal was: 0.50; 0.83; 0.33; 0.33; 0.67.  
Therefore the average TS=4.28+/-0.75 hrs.  The ratio between the number of cells 
in S phase (GFP+EdU+) and the total GFP+ proliferating population (GFP+Ki67+ 
cells) is proportional to the ratio TS/TC (31).  We estimated this ratio for each 
animal (0.21; 0.29; 0.27; 0.25; 0.18) and calculated an average TC=GFP+Ki67+ 
cells xTS/GFP+EdU+=17.24+/-1.86 hrs.  
Since the DA method focuses on the initial cohort of cells exiting the S 
phase, it over-represents the fastest cycling cells.  Yet, TS and TC calculated by 
both the DA and CL methods were similar, suggesting that the population of 
actively dividing B1 cells is fairly homogeneous.   
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We next applied the percent of labeled mitosis (PLM) method (33) for B1 
cells  (for a detailed description of the PLM method see below and Fig. 3L). 
hGFAP::GFP mice received a single injection of CldU and were analyzed at 
survivals ranging between 30’ and 8 hrs for the number of triple-labled 
(GFP+pHH3+CldU+) cells.  Given the low number of GFP+pHH3+ B1 cells in our 
material, we only analyzed the period from the initial appearance of mitotic B1 
cells to the time when all of these cells were triple-labeled.  No triple labeled cells 
were observed at 30’ suggesting that TG2 >/= 30’.  As CldU+GFP+ cells 
completed G2, the number of mitotic GFP+pHH3+CldU+ cells increased reaching 
100% by 6 hrs (Fig. S1W).   This indicates that TG2+TM for hGFAP::GFP cells is 
</= 6 hrs.  We did not use the PLM method to estimate TC and TS  for B1 cells 
(see discussion).  
 
Ascl1+ Cells are Heterogeneous in their Cell Cycle Dynamics 
    Ascl1+ nuclei were found in the V-SVZ under the ependymal layer.  The 
majority of Ascl1+ cells were actively proliferating; 52% of Ascl1+ cells were 
labeled 30’ after a single EdU injection, and a large fraction of Ascl1+ cells 
(89.15+/-1.72%) was labeled by Ki67.  The majority of Ascl1+ cells correspond to 
actively dividing intermediate progenitors C cells (23).  
C cells: CL method 
    Wild type mice received 1 to 10 injections of EdU (separated by 2 hrs intervals; 
n=5 for each time point) and were sacrificed 30’ after the last injection (see 
Methods and Fig. 3A-D).  As with the B1 cells, the total number of Ascl1+ cells 
remained constant for all time points studied, indicating that EdU was not toxic to 
Ascl1+ cells for the duration of the CL experiment.  The LI of Ascl1+ cells 
progressively increased up to 10 hrs before reaching a plateau.  We used two 
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regression lines (a & b) and calculated the GF, LI0 and TC-TS (Fig. 3A-D) using 
the same method as indicated above for hGFAP::GFP cells. The GF (87.11+/-
0.46%) calculated by the CL was similar to the ratio of Ascl1+Ki67+/Ascl1+ cells 
(89.15+/-1.72%, p=0.47, n=5).  Using the equations described above for the 
hGFAP::GFP+ cells, we calculated for the Ascl1+ population a TC=25.44 hrs and  
TS =14.80 hrs. 
C cells: DA method 
    Mice received one injection of CldU followed by an injection of EdU 3 hrs later.  
30’ after EdU, mice were killed, and the number of Ascl1+CldU+EdU- cells (cells 
that have exited the S phase between the two injections) was quantified in whole 
mounts (Fig. 3E-F).  We also counted the number of Ascl1+EdU+ labeled cells (in 
S phase) and from the ratio of Ascl1+CldU+EdU-/Ascl1+EdU+ cells (n=5; 0.20; 
0.19; 0.21; 0.27; 0.22), we calculated the average TS=12.20+/-1.56 hrs.  We next 
used the percent of Ki67+Ascl1+ cells (89.15+/-1.72%) as an estimate of the 
population of Ascl1+ cells that is actively dividing to determine the average 
TC=18.21+/-4.15 hrs (Fig. 3E,F).   Consistent with the observations made above 
using the CL method, these data show that Ascl1+ cells have a long TS.  Given 
how long C cells remain in the S phase this method may overestimate TS.  We 
therefore used an additional method to determine cell cycle dynamics for the 
Ascl1 population. 
C cells: percent of labeled mitosis (PLM). 
    In order to estimate TS and TC  with a different approach and determine TG2, TM 
and TG1  we used the PLM method (33).  Mice received a single CldU injection 
and were killed at different time points (n=5 for each time point).  Whole mounts 
of the V-SVZ were stained for Ascl1, CldU, and for the mitotic marker pHH3.  The 
number of pHH3+ Ascl1+ cells was constant for all time points studied, indicating 
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that neither experimental manipulations nor the incorporation of CldU interfered 
with the cell cycle dynamics of Ascl1+ cells (Fig. S2G-J).  For each time point, we 
calculated the ratio of pHH3+Ascl1+CldU+/Ascl1+pHH3+ cells (Fig. 3G-M) (33). 
30’ after the CldU injection, CldU+Ascl1+ cells were all pHH3-, indicating that this 
cohort of CldU-labeled cells had not entered mitosis (Fig. 3L).  As this cohort 
transitioned through G2 and entered mitosis, triple-labeled cells appeared 
reaching 100% at T=TG2+TM.  From regression line “a” (Fig. 3L) we determined 
TG2=0.92 hrs (y=0) and TM=3.27 hrs (y=1).  A second regression line “b” 
describes the progressive decrease in triple labeled pHH3+Ascl1+CldU+ cells as 
the cohort of cells that incorporated CldU has completed mitosis and entered G1.  
The minimum is reached when the last CldU-labeled cell exited mitosis.  The 
interval between the time in which the first and the last Ascl1+CldU+ cell exited 
mitosis corresponds to: TS=13.55 hrs.  When CldU labeled cells re-entered 
mitosis for a second time, triple labeled cells appeared again (“c”).  The total TC 
can be measured by the time interval between two corresponding points (the 
midpoint) on the two ascending lines (33). Therefore from “a” and “c” we 
determined: TC=16.79 (see Material and Methods).  TG1 can be approximated to 
be 1.76 hrs, by the subtraction of TS+TG2+TM from TC  (34). This is about 10% of 
TC.  Considering that the GF for C cells was 87%, about 8.7% of all C cells in the 
V-SVZ should be in G1 phase at any one time.  
    The time estimated for each cell cycle phase by the PLM method corresponds 
to the fastest dividing Ascl1+ cells (rising time, the slope in line “a”).  The falling 
time course “b” is a reflection of the slower trailing population (33). The difference 
between the rising time and the falling time was 5.42 hrs, corresponding to 32% 
of TC for the rapidly dividing population. From this we estimated that the TC varied 
between 16.78 hrs and 22.21 hrs. and TS between 13.55 hrs and 17.92 hrs.    
10 
    About 1/4 of the population of Ascl1+ cells appears to be asynchronous since 
the second peak of triple labeled CldU+ Ascl1+ pHH3+ cells, indicating cells 
undergoing a second cell cycle, reached only 75%.  Consistent with the 
heterogeneity of TC for the Ascl1+ population, the number of triple-labeled cells at 
time points longer than 30 hrs became highly variable.  However, a third peak is 
clearly discernible at about 50 hrs as expected for a third division of Ascl1+ cells 
with a TC of approximately 20 hrs (Fig. 3L).  
    The three methods used indicate that Ascl1+ cells have a surprisingly long 
TS~14-18 hrs.  Interestingly, Ascl1+ cells are heterogeneous with respect to the 
length of TC.   Different types of neurons are derived from unique subregions of 
the postnatal and adult V-SVZ (18), (35).  Variability in the proliferation dynamics 
between regions could account for the observed heterogeneity. The posterior V-
SVZ had a slightly higher GF (by CL) and a slightly longer TC compared to the 
anterior V-SVZ (Fig. S2G-J).  However, TC or the lengths of the different cell cycle 
phases of Ascl1+ cells between these subregions was remarkably similar, 
suggesting that the heterogeneity observed among Ascl1+ cells occurs 
throughout the V-SVZ and is likely due to other factors (see discussion).   
Neuroblasts Continue to Divide with Cell Cycle Dynamics Similar to those of 
Fast Cycling C Cells 
    We next investigated the cell cycle parameters of the DCX+ cells (neuroblasts, 
A cells).  It has been previously shown that A cells continue to divide while 
migrating  (15), (36); we observed that 54.63% (+/-1.26; n=3) of the DCX+ cells 
were positive for Ki67 (Fig. 1). 
    Since A cells migrate rapidly away from the walls of the ventricle into the dorso-
lateral corner of the V-SVZ and into the rostral migratory stream, the proportion of 
labeled cells within our counting bin changes over time.  For this reason, methods 
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that employ long survivals (CL and long-term PLM) cannot be reliably used to 
calculate cell cycle dynamics of A cells  (16). We therefore used strategies that 
use short survivals:  the DA method and a short version of the PLM technique.   
A cells: DA method  
    C57/BL6 mice received one injection of CldU followed by an injection of EdU 3 
hrs later.  Mice were analyzed 30’ after EdU injection (n=3).  At this time 30.46+/-
2.33 % of all DCX+ cells were labeled by EdU  (n=3; Fig. 1) while 10.42+/-2.79% 
were labeled by CldU but not by EdU.  For each animal we calculated the ratio of 
DCX+CldU+EdU- to DCX+EdU+ (n=3; 0.26; 0.29; 0.58), and estimated TS  (see 
above; Fig. 4A; average TS = 9.03+/-2.00 hrs). 
    The ratio of DCX+EdU+ cells to DCX+Ki67 cells equals the ratio of TS to TC.  
We estimated this ratio for each animal (0.48; 0.56; 0.38) and calculated the 
average TC = 17.85+/-3.24 hrs 
A cells: PLM short method 
     We analyzed the initial appearance of mitosis among cells that had 
incorporated CldU following a single injection (50 mg/kg).  The number of mitotic 
(pHH3+) CldU+DCX+ triple-labeled cells was determined after 30’, 1, 2, 3, 4 and 
6 hrs (n=3 each time point).  30’ after injection, we did not observe any DCX+ 
cells that were labeled by CldU (0 out of 47 DCX+pHH3+ cells counted, n=4).  In 
contrast, the majority of DCX+pHH3+ cells were CldU+ at 5 and 6 hrs post 
injection (88.10+/-7.90 and 88.54+/-6.93%, respectively).  From the slope of the 
regression line before reaching the plateau (first 4 values), we determined: 
TG2=0.89 hrs and TM=3.97 hrs (Fig.4B).  Thus, neuroblasts had a TC, TG2 and TM 
similar to that of C cells, but had a shorter S phase and a longer G1 phase.  
  
Intermediate Progenitors of the V-SVZ Divide on Average 3-4 Times  
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Amplification in the V-SVZ lineage is critically dependent on the number of times 
intermediate progenitors divide. Our PLM analysis suggests that some C cells 
divide at least two times and possibly three, but given the heterogeneity in TC it is 
difficult to determine if additional divisions occur (Fig. 3). To better understand 
changes in the overall population of newly generated V-SVZ cells and infer a 
possible lineage progression, we injected CldU and counted the number of 
labeled hGFAP::GFP+, Ascl1+, and DCX+ cells at different survivals (Fig. 5B,C; 
n=3 to 8 each time point). The number of CldU+ cells (grey squares, 935+/-80 
cells/mm2) increased in the first 18 hrs (Fig. 5B) as cells undergo mitosis; then 
decreased and raised again at least three times. This suggests that the balance 
between addition of cells (by mitosis) and decrease (by migration, label dilution, 
and/or cell death) for the overall population is relatively stable during the first 2.5 
days.  Between 2.5 and 3 days, the population of CldU-labeled cells declined to a 
plateau of about 724+/-56 cells/mm2 that was maintained for the next 3.5 days. As 
expected, at all times studied, B1 cells only accounted for a small fraction (< 5 %; 
GFP+; blue squares in Fig. 5B, D) of dividing cells.  Three hrs after injection, 
49.57+/-2.73% of the CldU+ cells were DCX+ and 40.42+/-3.05% were Ascl1+.  
Over time, proliferating Ascl1+ cells decreased and remained relatively low 
between day 3.5 until day 7 (13.29+/-1.63% of the total CldU+ population).  This 
decrease was paralleled by an increase in DCX+CldU+ cells (79+/-4% at 3 days; 
Fig. 5B, D), suggesting that the decline in the overall population of CldU+ cells 
between 2.5 and 3.5 days (Fig. 5B, gray squares) occurs as many of the labeled 
C cells give rise to A cells that rapidly move away from the V-SVZ (Fig. 5B,D 
green and red squares). Given the TC calculated above for B1 and C cells, 2.5- 
3.5  days is sufficient for 3-4 divisions of these progenitors. CldU-labeled cells 
further decreased between 6.5 and 7 days as A cells continue to emigrate and 
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their replenishment from labeled C cells and by their own divisions comes to an 
end.   The rapid migration of A cells makes it difficult to determine how many 
times they divide.  The overall numbers of A cells between 3.5 and 6.5 days 
remained relatively constant, suggesting that addition by conversion from C cells, 
their own mitoses and their depletion by CldU dilution, emigration and cell death 
results in no appreciable accumulation in the V-SVZ.  The proportion of A:C=1.5:1 
cells can be explained by a lineage tree where C cells divide three times and A 
cells divide once (Fig. 6).  This is assuming little, or no cell death or that cell death 
affects both populations equally.  
    To independently estimate the number of times intermediate progenitor (C 
cells) divide, we calculated the ratio of Ascl1+ cells that were in S phase vs. 
Ascl1+ cells in other phases of the cell cycle (G2+M+G1) at different time points. 
Mice received one injection of CldU, followed by one injection of EdU at different 
intervals.  Mice were sacrificed 30’ after the EdU injection. CldU+ cells 
correspond to cells that underwent S phase at t=0, whereas cells labeled by EdU 
were in the S phase at the time animals were killed (n=3 for each time point).  
Most Ascl1+CldU+ cells were also labeled by EdU when the interval between the 
two injections was 2 hrs (Fig. 5G).  The number of Ascl1+CldU+EdU- cells 
increased as the cohort of CldU+ cells exited the S phase.  Between 10 and 22 
hrs, the number of Ascl1+CldU+EdU-, cells decreased as proliferating progenitors 
re-entered the S phase and incorporated EdU.  This time (22 hrs) is similar to the 
average TC of Ascl1+ cells determined above.  Within the first three days, three 
troughs corresponding to sequential S phases could be detected (black arrows in 
Fig. 5G), and possibly a fourth one at day 4 (grey arrow in Fig. 5G).  These data 
again indicate that C cells divide, with a cell cycle just short of one day, three to 
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four times.  However, one division is likely due to labeling of B1 cells that upon 
division gave rise to CldU+ Ascl1+ C cells. 
 
Discussion  
Our results indicate that the TC for the three main progenitor cells  in the adult V-
SVZ of adult mice was slightly shorter than one day (B1 cells: 17hrs; C cells: ~18-
25hrs; A cells: 18hrs; Fig. 6), but the TS for the actively dividing B1 cells was 
surprisingly short (4.5 hrs) compared to that of C cells (12-17 hrs) and A cells (9 
hrs; Fig. 6). In this study we only analyzed actively dividing GFAP+ cells. We 
cannot exclude that there is a population of quiescent B1 cells with a longer TC 
possibly associated with periods of quiescence (37). Interestingly, the short S 
phase and long G1 phase of the actively dividing B1 cells is similar to that of 
radial glia (38), the neural stem cells in development and the precursors of B1 
cells (39). Our results suggest that following the initial division of GFAP+ B1 cells, 
Ascl1+ C cells divide 3 times before turning into DCX+ A cells.  Since A cells 
actively migrate as they divide, it is difficult to determine how many times they 
undergo cell division; our results suggest they may divide once or twice before 
leaving the V-SVZ. 
   Tools for Studying the Cell Cycle Dynamics and their Limitations 
    Thymidine analogs have been instrumental to identify and follow the division of 
neural progenitors in the adult brain, but these analogs may label cells 
undergoing DNA repair or cell death (40), (41). Most, if not all, of the labeling we 
observed following EdU or CldU injections was associated with proliferation since: 
1) at short survivals (30’) EdU and CldU labeled similar ratios of the different cell 
types (hGFAP::GFP, Ascl1 and DCX) as mitotic marker pHH3 and proliferation 
marker Ki67;  2) the population of dividing Ascl1+ cells was similar using 
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cumulative EdU labeling or Ki67.  Toxicity for CldU or EdU was not observed at 
short survival times, consistent with previous reports (42).  However, at longer 
survival times the numbers for CldU- labeled cells were much higher compared to 
cells that incorporated EdU (Fig. S1B-I).  This suggests that EdU is toxic at longer 
survivals.  Consistently, pyknotic nuclei were common among V-SVZ cells one 
day after EdU treatment, but not in mice injected with CldU (Fig. S1B-I). Toxic 
effects of EdU, but not CldU, were also observed in primary cultures from V-SVZ 
24 hrs after treatment (Fig. S1B-I).  We therefore used EdU only in experiments 
shorter than 18 hrs and CldU in experiments that extended beyond the first cell 
cycle. 
    The estimation of cell cycle dynamics requires that dividing cells remain in the 
counting bin for the duration of the experiment (16); this condition is not met in 
sectioned brain tissue as A cells actively migrate tangentially. Earlier studies 
applying the CL method for the total dividing V-SVZ population in neonate (43) 
and adult mice report a shorter TC of 12-14 hrs (11) compared to the present 
results and others’ data (12), (14), (44). Those differences are likely due to the 
use of tissue sections in different planes, the migration of neuroblasts, and the 
heterogeneous nature of progenitors.  We have attempted to overcome some of 
these limitations by the use of V-SVZ whole mounts. The en-face view allows 
inclusion of a larger bin in a tangential plane.  However, we can only reduce, but 
cannot eliminated the effects of migration of neuroblasts, as a subpopulation of 
these cells is constantly moving away from V-SVZ into the rostral migratory 
stream.  For these reasons we employed only short survival methods (DA and 
first ascending slope in PLM) for the cell cycle analysis of A cells. 
Identification of Dividing Progenitors in the Adult V-SVZ. 
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   Precise estimates of cell cycle dynamics in the adult V-SVZ require 
identification of the different types of dividing progenitors  We have used 
hGFAP::-GFP mice to identify B1 cells and immunostaining for Ascl1 and DCX to 
label C and A cells, respectively (23), (26), (45). Most of the proliferating 
hGFAP::GFP+ astrocytes within the V-SVZ are,neural stem cells (1), (46) and 
express other astrocytic markers, such as Glast (47) and  AldH1-L1 (48).  
hGFAP::GFP mice reporter protein was more reliable for quantification of B1 cells 
than GLAST::DsRed, (49) and AldH1-L1::GFP (50) (Fig. S1J-V).  However, 
among the cells identified with any of these markers, including the hGFAP-GFP 
mice, there is also a small population of V-SVZ astrocytes that are non-
neurogenic, and we cannot exclude possible effects of this population from our 
analysis.   
    Since in our study, the majority of cells studied correspond to singly-labeled 
populations, we believe that our data reliably reflect the cell cycle dynamics of 
major progenitor stages in the V-SVZ.  However, progenitor cells are dynamic and 
constantly drifting to a new stage of differentiation and therefore stable progenitor 
stages may not exist in vivo, possibly explaining some of the heterogeneity we 
observe (see below).  Consistently, we observed a few cells that express markers 
for two cell types, hGFAP::GFP and Ascl1 (B1 and C cell markers) or Ascl1 and 
DCX (C and A cells).  The population of cells double-labeled by hGFAP::GFP and 
Ascl1 was small (<3%).  In “knock-in” Ascl1::Cre ER T2/+ mice, the reporter is 
expressed mainly in intermediate progenitors and in a small subset of neural stem 
cells  (29). In another study, 36% of GFAP+EGFR+ cells are found faintly Ascl1+, 
(28), suggesting that the expression of EGFR may be associated with this 
transitional stage.  Interestingly, about 11% of Ascl1+ cells were also DCX+.  This 
suggests that newly generated cells that have begun neuronal differentiation 
17 
maintain features associated with the intermediate progenitor stage including 
proliferation. 
     Ascl1, which activates expression of the proneurogenic program, also has 
pivotal roles in promoting the G1-S and G2-M transitions (23), (51). During 
development Ascl1 and Hes1 oscillate in opposite directions during cell cycle with 
high Hes1 expression in G1 (52). If Ascl1 also fluctuates in the adult V-SVZ, the 
fraction of C cells labeled by Ascl1 may vary along the cell cycle and we may 
have underestimated the total population of C cells. This may also explain the 
short G1 in our PLM estimates (Fig. 6). The TC of C cells may, thus, be somewhat 
longer than calculated. 
Origin of C Cell Cycle Heterogeneity 
     Our data indicate that C cells are heterogeneous with a TC that varied between 
18 and 25 hrs.  In the PLM analysis the rising and falling dynamics during the first 
cycle (Fig. 5L) suggested a difference of about 5 hrs in TC between the fastest 
and slowest dividing Ascl1+ cells (33). This heterogeneity did not result from 
differences in the cell cycle dynamics in different subregions of the V-SVZ (Fig. 
S2G-J).  We found no significant changes in the number of cells incorporating 
EdU, nor in the number of mitotic pHH3+ V-SVZ cells at different times of the day 
both for the hGFAP::GFP+ and Ascl1+ cells (Fig. S2A-E). Instead, C cell’s cell 
cycle heterogeneity could be due to differences in TC between first generation C 
cells (those derived from B1) and subsequent generations.  Interestingly, in vitro 
time-lapse recording reported a deceleration in the cell cycle as intermediate 
progenitors progress through the lineage (53).   
Cell Cycle Dynamics and Lineage Progression 
    Our data suggest that following the division of B1 cells, there are 3 amplifying 
divisions associated to the proliferation of C cells, and 1 or 2 divisions associated 
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to the division of A cells (Fig. 6).  From our estimated cell cycle transit time, the 
generation of the initial C cells can occur in less than a day with the following 
amplification of C cells completed in 3.5-4 days. Consistent with previous reports 
(5), (6), (7), an important fraction of the proliferating cells in the V-SVZ 
corresponded to A cells. The additional division(s) of these neuroblasts further 
amplifies the number of new neurons as illustrated in Fig. 6. If A cells divide once 
or twice, it should take an additional 17-40 hrs to complete the lineage.  This is a 
total of 4-6 days from the initial division of a B1 cell to the generation of 
postmitotic young neurons. This is consistent with the observations that during 
regeneration following antimitotic treatment, A cells are first observed at 4.5 days 
(54),  and following a single CldU injection, the majority of proliferating cells 
leaves the V-SVZ after 6-7 days (Fig. 5).   
    The GF for hGFAP::GFP cells was 8.6%; these cells likely correspond to the 
population of activated B1 cells (28).  We counted a total of 6200+/-200 
hGFAP::GFP cells in the  V-SVZ of 2-month-old mice.  Therefore, the number of 
dividing hGFAP::GFP cells in the V-SVZ at any one time is 533+/-17 cells.  With a 
TC  for B1 cells of ~17 hr, we can extrapolate that in a day, about 711+/-23 B1 
cells divide in the V-SVZ. With this initial number of primary progenitors dividing 
every day, 4 amplifying divisions of intermediate progenitors should suffice to 
generate  ~10,000 A cells, which is an estimated of the number of migrating 
young neurons that moves along the rostral migratory stream every day  (5), (15),  
(Fig. 6A).  This assumes no cell death or derivation of daughter cells into 
alternative lineages.  Since there is some level of cell death (6), (11), (55), in the 
V-SVZ, and some of the progeny of intermediate proliferating progenitors is 
diverted into the production of oligodendrocytes (56), (57), we conclude that on 
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average the neurogenic V-SVZ lineage from B1 to A cells likely includes 4-5 
amplifying divisions (including those of C and A cells). 
    Consistent with our observations, a recent in vitro study suggests that slowly 
dividing primary astroglial progenitors divide asymmetrically to generate actively 
dividing cells that continue to express astroglial markers (53).  The latter likely 
corresponds to the activated hGFAP::GFP cells we studied here.  Costa et al. 
(53) also found approximately 5 stages of amplification, which should result in 
similar numbers of generated A cells from activated B1 cells as calculated above.  
It is interesting that the behavior of isolated progenitors in vitro, without exposure 
to growth factors, is so similar to that inferred here in vivo, further supporting the 
view that lineage progression may be largely cell-autonomously determined (53). 
As discussed above, the average TC for Ascl1+ cells was slightly longer than the 
average TC for B1 and A cells.  TM and TG2 were, however, comparable for all 
three types of progenitors.  Interestingly, C cells had a TS 3.5-4.3 fold as long as 
that of B1 cells and 1.4-2.1 fold longer than that of A cells (Fig. 6B). Pluripotent 
stem cells and immortalized cell lines also have proportionally longer TS (58).  
Checkpoints in G1 and S phases prevent the replication of damaged DNA (59) 
and slow down S phase progression (60).  It is possible that C cells undergo 
extensive DNA damage control, extending the TS. Other factors -slower rate of 
nucleotides synthesis (61), slower fork elongation during replication (62), or 
increased heterochromatin (63)- could all contribute to a longer TS (64).  
     Consistently with the current observations, intermediate progenitors in the  
developing cortical SVZ have a longer S phase compared to cortical VZ neural 
stem cells. Intermediate progenitors’ long TS could be associated to changes in 
the patterns of gene expression as these cells progress along the neurogenic 
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lineage (see above). A change in gene expression may require dramatic 
epigenetic changes  (64) and this may slow down cell cycle progression. 
      With the caveat discussed above of possible oscillation in Ascl1 expression, 
PLM experiments also suggest that C cells have a surprisingly short TG1, shorter 
than those of A and B1 cells.  During cortical development, TG1 is longer in 
primary apical progenitors compared to committed neuronal intermediate 
progenitors in the SVZ (65), (66),  (67).  It has been proposed that the time 
available during G1 for the accumulation of cell fate factors determines whether 
the cell differentiates or re-enters the cell cycle (65); a short TG1 may favor 
proliferation (68) while lengthening of G1 may trigger differentiation (69). This is 
consistent with our observation that C cells have a very short TG1, likely related to 
their repeated divisions before they begin neural differentiation into A cells. 
 
 Concluding Remarks 
This study provides fundamental information to understand lineage progression 
from neural stem cells to their progeny in the adult brain.  The study reveals a 
number of unexpected observations; a subpopulation of B1 cells was actively 
dividing, with a relatively short cell cycle compared to that of intermediate 
progenitors, C cells, which have long S and short G1 phases.  The work also 
highlights the importance of neuroblast division for the overall high number of new 
neurons produced in the adult V-SVZ.  This also explains why  A cells account for 
almost half of all actively dividing cells (Fig. 6).  It is reassuring that our cell cycle 
estimates predict quite accurately the overall number of different types of dividing 
progenitors observed at any one time, the overall progression from one stage to 
the next, the total number of young neurons produced, and the timing of 
clearance of dividing cells from the V-SVZ as neuroblasts move into the rostral 
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migratory stream and olfactory bulb.  The cell cycle progression described here 
for the different progenitor cells provides an important new understanding of how 
neurogenesis is maintained in the adult brain. 
Material and Methods 
    Animals Mice were housed and treated according to the guidelines from the 
UCSF Laboratory Animal Care and Use Committee. 376 2-month-old male 
C57/BL6 (Charles River) mice were used for all the controls of the DA and the 
study of C and A cells.  For B1 cell analysis, we used 109 hGFAP::GFP mice 
(FVB/N-TgGFAPGFP14Mes/J; Jackson Labs). This many animals were required 
because from each animal only two whole mount preparations can be obtained. 
    Whole mount preparation Mice were deeply anesthetized with 2.5% 
tribromoethanol (Avertin), and perfused transcardially with 0.9% NaCl.  Brains 
were removed, the lateral and medial ventricular walls were immediately 
dissected out in warm Leibovitz’s L15 medium as previously published  (3), (17), 
(70).  In all the experiments described here, whole mounts were fixed in 4% PFA, 
0.1% Triton for 6hrs, then kept in PBS-Sodium azide at 4°C until 
immunohistochemical processing.   
    Whole mounts were incubated for 48 hrs at 4°C with  primary antibodies, 
followed by 48hrs at 4°C with the appropriate secondary antibodies (Tab. S1).  
For mounting, whole mounts were then further dissected and embedded with 
Aqua Poly/Mount mounting medium (Polysciences Inc., Warrington PA).  
    Cell quantifications Images of defined V-SVZ subregions (Fig. S1A) were 
acquired with a Leica SP5 confocal microscope (Leica, Germany).  Both 
hemispheres of 5 animals for each time point were analyzed.  Four non-
overlapping high-power fields (386 x 386 μm2) of the lateral wall of the V-SVZ 
corresponding to the anterior dorsal (AD), anterior ventral (AV), posterior dorsal 
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(PD) posterior ventral (PV) and one anterior ventral field in the medial wall (MV) 
were analyzed for each hemisphere (Fig. S1A). 
    Double and triple labeled cells were counted tri-dimensionally using the Imaris 
software (Imaris, Bitplane, CH). All values are expressed as number of cells/mm2 
or as ratios..  Data were analyzed by Student’s t-Test, with a value of p≤0.05 
considered statistically significant. 
   Thymidine analogs CldU (5-Chloro-2′-deoxyuridine; Sigma) and EdU (5-ethynyl-
2'-deoxyuridine; Invitrogen) were dissolved at 10 mg/ml in sterile PBS and 
administered by an intraperitoneal injection.  Since their molecular weight is 
similar (CldU 262.65 g/mol and EdU 252.22 g/mol) we used the same dose of 50 
mg/kg for both analogs.   
    For CldU labeling, samples were pretreated with formamide SSC (20), 
denatured with 0.5 M of hydrochloric acid for 30’ at 37°C, washed with boric buffer 
for 10’ and processed for rat anti-BrdU antibody staining (Tab. S1).  EdU was 
detected using a commercial kit (Invitrogen) at the end of the 
immunohistochemical reactions. 
 (a) For in vivo controls, mice received subsequently one injection of CldU 
and one of EdU two hrs later or vice versa, and were sacrificed after 30’.  
Alternatively, mice received either one injection of CldU or EdU, or both 
(50mg/kg), 30’ before fixation.  Whole mounts were prepared and stained as 
explained above.  The average number of cells/mm2 labeled by EdU was 
compared with the counts for CldU labeling.  Both analogs had the same 
efficiency with little or no cross-reaction between them.  
     Moreover, to ensure that the labeling with CldU did not impair the ability of 
cells to incorporate EdU 2hrs later, we counted the number of EdU labeled cells 
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30’ after the injection in mice that received only EdU to mice previously treated 
with CldU.  
 (b) Evaluation of the toxicity of thymidine analogues: Primary cultures 
were prepared from the V-SVZ from mice that received EdU in vivo 1 hr before 
the dissection, and analyzed for EdU-labeling 2 hrs and 24 hrs later, but not from 
CldU treated mice.  Plates were fixed 2 hrs and 24 hrs later and stained for either 
CldU or EdU.  In addition, C57/BL6 mice received either one injection of CldU or 
EdU (50mg/Kg), and were killed at different time points.  Whole mounts were 
processed as described above.  The number of labeled cells was counted along 
with the number of labeled Ascl1+ cells (Fig. S1B-I). 
Cell cycle determination  All the cell cycle analysis experiments started at 9 AM. 
(a) CL method:  2-months-old mice (C57/BL6; hGFAP::GFP) received 1 to 
16 repeated injections of EdU (50mg/kg, one every 2hrs).  Two hrs is shorter than 
the S phase for V-SVZ cells (see results), assuring that all V-SVZ cells dividing 
during the experiment would be labeled by EdU  (16).  Mice were killed 30’ after 
the last injection, and the lateral and medial wall of the lateral ventricle were 
dissected. Whole mounts were stained for either GFP or Ascl1 and EdU (as 
described above).  
    For each time point, 5 mice (10 hemispheres) were analyzed.  EdU+, GFP+ (or 
Ascl1+) and double-labeled cells within 5 subregions of the V-SVZ (Fig. S1A) 
were acquired in z-stacks with the confocal microscope and quantified using 
Imaris software.    
    The labeled fraction of a population (number of hGFAP::GFP+EdU+ or 
Ascl1+EdU+ cells divided by the total number of hGFAP::GFP+ or Ascl1+ cells, 
respectively) was counted and the labeling indexes  (16) were determined and 
averaged for each survival time. CL data can be described by two regression 
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lines: a) least squares fit lines through the data points prior the plateau of LI; b) 
the plateau y=GF (Fig. 2A-E; 3A-D). The intersect of the first regression line with 
the y axis is defined as the initial labeling index (LI0) and corresponds to 
(GFxTS)/TC  (16), (34).  The time (x axis) at which the plateau is reached (when 
the two regression lines intersect) equals TC minus TS.   
By resolving the two equations a) and b) we calculated TC and TS.  
(b) DA method  2-months-old mice were injected intraperitoneally with 
50mg/kg of CldU. Two (hGFAP::GFP n=5)  or three  (C57/BL6 n=10) hrs later we 
injected EdU at the same dose, killed the mice 30’ later, and prepared whole 
mounts.  Whole mounts were immunostained for cell type specific markers (GFP, 
Ascl1 or DCX), CldU and EdU were detected as described above.  In each 
population (B1, C, A cells) the ratio between the cells labeled only by CldU (or by 
EdU) to the total population (GFP+ or Ascl1+ or DCX ) was determined (Fig.  2F-
H;  3E-F; 4A, B).  Cells that had exited the S phase between the two injections 
were labeled only by the first analog, while the total number of cells in the S 
phase were labeled by the second analog.  The ratio of these two values is equal 
to the ratio of the interval between the two injections over the length of the S 
phase (for each cell type: CldU+EdU-/EdU+=3 hrs/TS).  From this equation we 
estimated TS.  
(c) PLM method: Mice received a single injection of 50mg/Kg CldU and 
whole mounts were prepared after different time points (hGFAP::GFP mice were 
sacrificed at 30’, 2, 4, 6, and 8 hrs; C57/BL6 mice were sacrificed at 30’, 2, 4, 6, 8, 
10,12,14,16,18, 20, 22, 24, 26, 28, 30, 36, 42, 48, 54, 60, 66, 72 hrs  after CldU 
injection; (Fig. 3G-K; 4C-E; S1W).  For each population (B1, C, A cells) the 
number of mitotic (pHH3+) cells and mitotic CldU+ cells were measured for each 
time point.  Nuclei with a homogeneous staining for pHH3 were counted as 
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labeled mitosis (Fig. 3H).   Nuclei with few bright discrete dots of nuclear pHH3 
labeling were not counted as these correspond to cells that are still in the G2 
phase (71).  
For each cell type  we calculated the ratio of CldU+ labeled mitoses to the 
total number of mitoses (e.g. Ascl1+CldU+pHH3+/Ascl1+pHH3+) for each time 
point. The values of this time course were plotted and described by regression 
lines.  
 By calculating the least square fit for the ascending, plateau, and 
descending lines, we can calculate  (33): TG2 (line “a”; y = 0), TG2+TM (line “a” for 
y=1), TG2+TM+TS (line “b” y = 0), TC (difference from the middle of the line “c”, 
y=0.36 and the middle of the line “a” y=0.50; Fig. 3G-I). 
Estimations of the number of C cell divisions  2-month-old mice (C57/BL6; n=69) 
received one initial injection of CldU (50mg/kg), followed at different intervals by 
one EdU injection (50mg/kg).  Mice were sacrificed 30’ after the EdU injection (n= 
3 for each time point).  Whole mounts were stained for Ascl1, CldU, and EdU. 
     Cells that were only labeled by CldU (EdU-) correspond to cells that underwent 
S phase at t=0, progressed through the cell cycle and were in a different cell cycle 
phase at the time of EdU injection (see above). By analyzing the ratio of 
Ascl1+CldU+EdU-/Ascl1+EdU+ cells at different time points we estimated the 
number of times a cohort of cells re-enters the S phase, i.e. incorporated EdU.  At 
short intervals between the two analog administrations, most of  the Ascl1+CldU+ 
cells are also labeled by EdU. The number of Ascl1+CldU+EdU- cells increased 
as the cohort of CldU+ cells exited S phase and decreased again at longer time 
points as these cells re-entered S phase. Every time the cohort of cells underwent 
a S phase the ratio Ascl1+CldU+EdU-/Ascl1+EdU+ reached a minimum.  From 
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the number of troughs we estimated the number of cell divisions of the C cell 
population and from the intervals between them we estimated TC.  
 
Acknowledgements 
We thank L. Fuentealba, D. Hansen, Y.-G. Han, R. Ihrie, T. Nguyen,  C. Harwell, F. Luzzati, A. 
Buffo and C. Rolando for the discussion. This work was support by NIH NS 28478, the John G. 
Bowes Research Fund, European Community’s Seventh Framework program (FP7/2007-2013) 
under the grant agreement n°220005 and Regione Piemonte “Ricerca Sanitaria Finalizzata 2008”.  
AA-B is the Heather and Melanie Muss Endowed Chair of Neurological Surgery at UCSF.  GP is 
supported by European Community’s Seventh Framework program (FP7/2007-2013) under the 
grant agreement n°220005. KO is supported by German Research Foundation (Deutsche 
Forschungsgemeinschaft).  
 
 References 
 
 
1. Doetsch F, Caillé I, Lim DA, García-Verdugo JM, & Alvarez-Buylla A (1999) 
Subventricular zone astrocytes are neural stem cells in the adult mammalian 
brain.  Cell 97(6):703-716. 
2. Lim DA, et al. (2000) Noggin antagonizes BMP signaling to create a niche for 
adult neurogenesis.  Neuron 28(3):713-726. 
3. Mirzadeh Z, Merkle FT, Soriano-Navarro M, Garcia-Verdugo JM, & Alvarez-Buylla 
A (2008) Neural stem cells confer unique pinwheel architecture to the ventricular 
surface in neurogenic regions of the adult brain.  Cell Stem Cell 3(3):265-278. 
4. Fuentealba LC, Obernier K, & Alvarez-Buylla A (Adult neural stem cells bridge 
their niche.  Cell Stem Cell 10(6):698-708. 
5. Luskin MB, Zigova T, Soteres BJ, & Stewart RR (1997) Neuronal progenitor cells 
derived from the anterior subventricular zone of the neonatal rat forebrain 
continue to proliferate in vitro and express a neuronal phenotype.  Mol Cell 
Neurosci 8(5):351-366. 
6. Lois C, García-Verdugo JM, & Alvarez-Buylla A (1996) Chain migration of 
neuronal precursors.  Science 271(5251):978-981. 
7. Menezes JR, Smith CM, Nelson KC, & Luskin MB (1995) The division of neuronal 
progenitor cells during migration in the neonatal mammalian forebrain.  Mol Cell 
Neurosci 6(6):496-508. 
8. Petreanu L & Alvarez-Buylla A (2002) Maturation and death of adult-born 
olfactory bulb granule neurons: role of olfaction.  J Neurosci 22(14):6106-6113. 
9. Imayoshi I, et al. (2008) Roles of continuous neurogenesis in the structural and 
functional integrity of the adult forebrain.  Nat Neurosci 11(10):1153-1161. 
10. Lazarini F & Lledo PM (2011) Is adult neurogenesis essential for olfaction?  
Trends Neurosci 34(1):20-30. 
27 
11. Morshead CM & van der Kooy D (1992) Postmitotic death is the fate of 
constitutively proliferating cells in the subependymal layer of the adult mouse 
brain.  J Neurosci 12(1):249-256. 
12. Lewis PD (1968) A quantitative study of cell proliferation in the subependymal 
layer of the adult rat brain.  Exp Neurol 20(2):203-207. 
13. Sajad M, et al. (2011) Cytokinetics of adult rat SVZ after EAE.  Brain Res 
1371:140-149. 
14. Schultze B & Korr H (1981) Cell kinetic studies of different cell types in the 
developing and adult brain of the rat and the mouse: a review.  Cell Tissue Kinet 
14(3):309-325. 
15. Lois C & Alvarez-Buylla A (1994) Long-distance neuronal migration in the adult 
mammalian brain.  Science 264(5162):1145-1148. 
16. Nowakowski RS, Lewin SB, & Miller MW (1989) Bromodeoxyuridine 
immunohistochemical determination of the lengths of the cell cycle and the DNA-
synthetic phase for an anatomically defined population.  J Neurocytol 18(3):311-
318. 
17. Mirzadeh Z, Doetsch F, Sawamoto K, Wichterle H, & Alvarez-Buylla A (2010) The 
subventricular zone en-face: wholemount staining and ependymal flow.  J Vis Exp 
(39). 
18. Merkle FT, Mirzadeh Z, & Alvarez-Buylla A (2007) Mosaic organization of neural 
stem cells in the adult brain.  Science 317(5836):381-384. 
19. De Marchis S, et al. (2007) Generation of distinct types of periglomerular olfactory 
bulb interneurons during development and in adult mice: implication for intrinsic 
properties of the subventricular zone progenitor population.  J Neurosci 
27(3):657-664. 
20. Leuner B, Glasper ER, & Gould E (2009) Thymidine analog methods for studies 
of adult neurogenesis are not equally sensitive.  J Comp Neurol 517(2):123-133. 
21. Taupin P (2007) BrdU immunohistochemistry for studying adult neurogenesis: 
paradigms, pitfalls, limitations, and validation.  Brain Res Rev 53(1):198-214. 
22. Belluzzi O, Benedusi M, Ackman J, & LoTurco JJ (2003) Electrophysiological 
differentiation of new neurons in the olfactory bulb.  J Neurosci 23(32):10411-
10418. 
23. Parras CM, et al. (2004) Mash1 specifies neurons and oligodendrocytes in the 
postnatal brain.  EMBO J 23(22):4495-4505. 
24. Nacher J, Crespo C, & McEwen BS (2001) Doublecortin expression in the adult 
rat telencephalon.  Eur J Neurosci 14(4):629-644. 
25. Zhuo L, et al. (1997) Live astrocytes visualized by green fluorescent protein in 
transgenic mice.  Dev Biol 187(1):36-42. 
26. Platel JC, Gordon V, Heintz T, & Bordey A (2009) GFAP-GFP neural progenitors 
are antigenically homogeneous and anchored in their enclosed mosaic niche.  
Glia 57(1):66-78. 
27. Doetsch F, Garcia-Verdugo JM, & Alvarez-Buylla A (1997) Cellular composition 
and three-dimensional organization of the subventricular germinal zone in the 
adult mammalian brain.  J Neurosci 17(13):5046-5061. 
28. Pastrana E, Cheng LC, & Doetsch F (2009) Simultaneous prospective purification 
of adult subventricular zone neural stem cells and their progeny.  Proc Natl Acad 
Sci U S A 106(15):6387-6392. 
29. Kim Y, et al. (2010) Dopamine stimulation of postnatal murine subventricular zone 
neurogenesis via the D3 receptor.  J Neurochem 114(3):750-760. 
30. Sarli G, Benazzi C, Preziosi R, & Marcato PS (1994) Proliferative activity 
assessed by anti-PCNA and Ki67 monoclonal antibodies in canine testicular 
tumours.  J Comp Pathol 110(4):357-368. 
31. Hayes NL & Nowakowski RS (2000) Exploiting the dynamics of S-phase tracers 
in developing brain: interkinetic nuclear migration for cells entering versus leaving 
the S-phase.  Dev Neurosci 22(1-2):44-55. 
28 
32. Nowakowski RS, Caviness VS, Takahashi T, & Hayes NL (2002) Population 
dynamics during cell proliferation and neuronogenesis in the developing murine 
neocortex.  Results Probl Cell Differ 39:1-25. 
33. Cai L, Hayes NL, & Nowakowski RS (1997) Local homogeneity of cell cycle 
length in developing mouse cortex.  J Neurosci 17(6):2079-2087. 
34. Takahashi T, Nowakowski RS, & Caviness VS (1993) Cell cycle parameters and 
patterns of nuclear movement in the neocortical proliferative zone of the fetal 
mouse.  J Neurosci 13(2):820-833. 
35. Young KM, Fogarty M, Kessaris N, & Richardson WD (2007) Subventricular zone 
stem cells are heterogeneous with respect to their embryonic origins and 
neurogenic fates in the adult olfactory bulb.  J Neurosci 27(31):8286-8296. 
36. Menezes JR & Luskin MB (1994) Expression of neuron-specific tubulin defines a 
novel population in the proliferative layers of the developing telencephalon.  J 
Neurosci 14(9):5399-5416. 
37. Chiasson BJ, Tropepe V, Morshead CM, & van der Kooy D (1999) Adult 
mammalian forebrain ependymal and subependymal cells demonstrate 
proliferative potential, but only subependymal cells have neural stem cell 
characteristics.  J Neurosci 19(11):4462-4471. 
38. Takahashi T, Nowakowski RS, & Caviness VS (1995) The cell cycle of the 
pseudostratified ventricular epithelium of the embryonic murine cerebral wall.  J 
Neurosci 15(9):6046-6057. 
39. Kriegstein A & Alvarez-Buylla A (2009) The glial nature of embryonic and adult 
neural stem cells.  Annu Rev Neurosci 32:149-184. 
40. Cooper-Kuhn CM & Kuhn HG (2002) Is it all DNA repair? Methodological 
considerations for detecting neurogenesis in the adult brain.  Brain Res Dev Brain 
Res 134(1-2):13-21. 
41. Breunig JJ, Arellano JI, Macklis JD, & Rakic P (2007) Everything that glitters isn't 
gold: a critical review of postnatal neural precursor analyses.  Cell Stem Cell 
1(6):612-627. 
42. Zeng C, et al. (2010) Evaluation of 5-ethynyl-2'-deoxyuridine staining as a 
sensitive and reliable method for studying cell proliferation in the adult nervous 
system.  Brain Res 1319:21-32. 
43. Smith CM & Luskin MB (1998) Cell cycle length of olfactory bulb neuronal 
progenitors in the rostral migratory stream.  Dev Dyn 213(2):220-227. 
44. Thomaidou D, Mione MC, Cavanagh JF, & Parnavelas JG (1997) Apoptosis and 
its relation to the cell cycle in the developing cerebral cortex.  J Neurosci 
17(3):1075-1085. 
45. Yang HK, et al. (2004) Distribution of doublecortin expressing cells near the 
lateral ventricles in the adult mouse brain.  J Neurosci Res 76(3):282-295. 
46. Ishii Y, et al. (2008) Characterization of neuroprogenitor cells expressing the 
PDGF beta-receptor within the subventricular zone of postnatal mice.  Mol Cell 
Neurosci 37(3):507-518. 
47. Anthony TE & Heintz N (2008) Genetic lineage tracing defines distinct neurogenic 
and gliogenic stages of ventral telencephalic radial glial development.  Neural Dev 
3:30. 
48. Cahoy JD, et al. (2008) A transcriptome database for astrocytes, neurons, and 
oligodendrocytes: a new resource for understanding brain development and 
function.  J Neurosci 28(1):264-278. 
49. Regan MR, et al. (2007) Variations in promoter activity reveal a differential 
expression and physiology of glutamate transporters by glia in the developing and 
mature CNS.  J Neurosci 27(25):6607-6619. 
50. Yang Y, et al. (2011) Molecular comparison of GLT1+ and ALDH1L1+ astrocytes 
in vivo in astroglial reporter mice.  Glia 59(2):200-207. 
51. Castro DS, et al. (2011) A novel function of the proneural factor Ascl1 in 
progenitor proliferation identified by genome-wide characterization of its targets.  
Genes Dev 25(9):930-945. 
29 
52. Baek JH, Hatakeyama J, Sakamoto S, Ohtsuka T, & Kageyama R (2006) 
Persistent and high levels of Hes1 expression regulate boundary formation in the 
developing central nervous system.  Development 133(13):2467-2476. 
53. Costa MR, et al. (2011) Continuous live imaging of adult neural stem cell division 
and lineage progression in vitro.  Development 138(6):1057-1068. 
54. Doetsch F, Garcia-Verdugo JM, & Alvarez-Buylla A (1999) Regeneration of a 
germinal layer in the adult mammalian brain.  Proc Natl Acad Sci U S A 
96(20):11619-11624. 
55. Richardson SJ, Lemkine GF, Alfama G, Hassani Z, & Demeneix BA (2007) Cell 
division and apoptosis in the adult neural stem cell niche are differentially affected 
in transthyretin null mice.  Neurosci Lett 421(3):234-238. 
56. Menn B, et al. (2006) Origin of oligodendrocytes in the subventricular zone of the 
adult brain.  J Neurosci 26(30):7907-7918. 
57. Gonzalez-Perez O, Romero-Rodriguez R, Soriano-Navarro M, Garcia-Verdugo 
JM, & Alvarez-Buylla A (2009) Epidermal growth factor induces the progeny of 
subventricular zone type B cells to migrate and differentiate into oligodendrocytes.  
Stem Cells 27(8):2032-2043. 
58. Singh SK, et al. (2004) Identification of human brain tumour initiating cells.  
Nature 432(7015):396-401. 
59. Woo RA & Poon RY (2003) Cyclin-dependent kinases and S phase control in 
mammalian cells.  Cell Cycle 2(4):316-324. 
60. Kastan MB & Lim DS (2000) The many substrates and functions of ATM.  Nat 
Rev Mol Cell Biol 1(3):179-186. 
61. Alexiades MR & Cepko C (1996) Quantitative analysis of proliferation and cell 
cycle length during development of the rat retina.  Dev Dyn 205(3):293-307. 
62. Lakhotia SC & Sinha P (1983) Replication in Drosophila chromosomes. X. Two 
kinds of active replicons in salivary gland polytene nuclei and their relation to 
chromosomal replication patterns.  Chromosoma 88(4):265-276. 
63. Shaw A, Olivares-Chauvet P, Maya-Mendoza A, & Jackson DA (2010) S-phase 
progression in mammalian cells: modelling the influence of nuclear organization.  
Chromosome Res 18(1):163-178. 
64. Herrick J (2011) Genetic variation and DNA replication timing, or why is there late 
replicating DNA?  Evolution 65(11):3031-3047. 
65. Calegari F & Huttner WB (2003) An inhibition of cyclin-dependent kinases that 
lengthens, but does not arrest, neuroepithelial cell cycle induces premature 
neurogenesis.  J Cell Sci 116(Pt 24):4947-4955. 
66. Lange C, Huttner WB, & Calegari F (2009) Cdk4/cyclinD1 overexpression in 
neural stem cells shortens G1, delays neurogenesis, and promotes the 
generation and expansion of basal progenitors.  Cell Stem Cell 5(3):320-331. 
67. Calegari F, Haubensak W, Haffner C, & Huttner WB (2005) Selective lengthening 
of the cell cycle in the neurogenic subpopulation of neural progenitor cells during 
mouse brain development.  J Neurosci 25(28):6533-6538. 
68. Hodge RD, D'Ercole AJ, & O'Kusky JR (2004) Insulin-like growth factor-I 
accelerates the cell cycle by decreasing G1 phase length and increases cell cycle 
reentry in the embryonic cerebral cortex.  J Neurosci 24(45):10201-10210. 
69. Salomoni P & Calegari F (2010) Cell cycle control of mammalian neural stem 
cells: putting a speed limit on G1.  Trends Cell Biol 20(5):233-243. 
70. Doetsch F & Alvarez-Buylla A (1996) Network of tangential pathways for neuronal 
migration in adult mammalian brain.  Proc Natl Acad Sci U S A 93(25):14895-
14900. 
71. Hendzel MJ, et al. (1997) Mitosis-specific phosphorylation of histone H3 initiates 
primarily within pericentromeric heterochromatin during G2 and spreads in an 
ordered fashion coincident with mitotic chromosome condensation.  Chromosoma 
106(6):348-360. 
 
30 
Figure legends 
Fig. 1. Characterization of dividing cells in the V-SVZ. Confocal analysis of 
whole mounts of the lateral wall of the lateral ventricle with examples of cells 
stained for different markers. In hGFAP::GFP mice, the majority of GFP+ cells 
were stained for GFAP (A). A small fraction of cells expressed both GFP and 
Ascl1 (B); for quantifications see text and (J, K).  Also a small fraction of Ascl1+ 
cells expressed DCX (C). Thirty minutes after EdU injection, a small fraction of 
EdU+ cells expressed GFP (in hGFAP::GFP mice, D), while the majority 
expressed Ascl1 (E) or DCX (F); for quantification see text and (L).  Consistently, 
the fraction of GFP+ cells (in hGFAP::GFP mice) labeled by mitotic marker pHH3 
was small (G).  Most of the pHH3+ cells were either Ascl1+ (H) or DCX+ (I); for 
quantification see text and (M).  Scale bars 50 μm. Arrows indicate double-
labeled cells; arrowheads single labeled cells. (L-M) A fraction (labeled “?”) of 
EdU+, or pHH3+ did not express GFP (B1 cells), Ascl1(C cells) or DCX (A cells) 
markers. (D-F, L) 30' after EdU injection. Means (n=3) ± SEM.  
 
Fig. 2. Length of cell cycle phases for hGFAP::GFP+ cells. (A-E) CL method. 
(A) Experimental outline; hGFAP::GFP mice received one to 16 injections of EdU 
every 2 hrs and were analyzed 30' after the last injection (n=5). (B, C) Confocal 
analysis of whole mounts of the lateral wall of the lateral ventricle. After 3 
injections (4.5 hrs) only 4.2+/-0.8% GFP+ cells were EdU+ (arrow; B) while after 
9 injections (16.5 hrs) the percentage of GFP+EdU+/GFP+ cells increased 
significantly to to 8.7+/-0.9% (n=3, p=0.0096; arrows; C) . (D) The ratio of double 
labeled cells within the GFP+ population increased over time, reaching a plateau 
at 13.22 hrs when the entire cycling population (GF) entered the S phase 
(diagram). Least square fit for line a: y=0.005x+0.022 R2 =0.897; GF=0.086. (E) 
Values for cells cycle parameters measured by CL.  (F-H) DA method. (F) 
Experimental outline; mice received an injection of CldU and 2 hrs later EdU; 
analysys 30' after EdU (n=3). GFP+CldU+EdU- cells have exited the S phase, 
while EdU+ cells are in S phase (diagram). (G) Confocal microscopy of triple-
labeled cell (arrow). (H) Quantification of TS and TC by the DA method. Scale bars 
25 μm. Means (n=3) ± SEM. 
 
Fig. 3. Length of cell cycle phases for Ascl1+ cells. For experimental outlines 
see Fig. 2. (A-D) CL method. (A,B) Confocal analysis of whole mounts of the 
lateral wall of the lateral ventricle. After 3 injections (4.5 hrs) 70.99+/-1.67% of 
Ascl1+ cells were labeled with EdU (arrows, A); after 18.5 hrs 86.70+/-1.16% 
Ascl1+ cells were double labeled (B). (C) Ratio of Ascl1+EdU+/Ascl1+ cells 
increased with additional injections of EdU reaching a plateau at 10.63 hrs when 
the entire cycling population (GF) has entered the S phase. (D) Cell cycle values 
as determined Cell cycle parameters quantified by the CL; Least square fit a: 
y=0.034x+0.506; R2=0.966; GF=0.87 (E-F) DA method. (E) Confocal microscopy 
of triple-labeled cells (arrows). (F) Quantification of TS and TC by the DA method. 
(G-M) PLM method. (G) Experimental outline; C57/BL6 mice received an injection 
of CldU and were analyzed for pHH3+ mitoses at different times (n=5) . (H, I) 
Confocal analysis of whole mounts of the lateral wall of the lateral ventricle after 
1hr (H) or 4hrs (I) after CldU (Ascl1+pHH3+ cells; arrowhead, 
Ascl1+pHH3+CldU+ cell; arrow). (J) The ratio of triple labeled cells 
(Ascl1+pHH3+CldU+) over the pHH3+Ascl1+ increased, reaching a plateau when 
the last CldU labeled cell exited mitosis. The fraction of labeled mitosis decreased 
during G1, but increased again as CldU+ cells re-entered mitosis. Least square fit 
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a: y=0.306x-0.281; R2 =0.836; b: y= -0.115x+2.040 R2 =0.880; c: y=0.140x-2.348 
R2=0.958 (K) Cell cycle phases quantified by PLM. Scale bars 25 μm. 
 
Fig. 4. Length of cell cycle phases for DCX+ cells. (A-B) DA method, for 
experimental outline see Fig. 2F. Confocal analysis at 3.5 hrs (triple-labeled cell; 
arrow). (B) TS and TC determined by DA. (C-E) Short PLM method (for 
experimental outline see Fig. 3G). (C) Confocal analysis 3 hrs after CldU (triple-
labeled cell; arrow). (D) Ratio of triple labeled cells (DCX+pHH3+CldU+) to mitotic 
DCX+ cells. (E) TG2 and TM quantified by PLM Least square fit a: y=0.268x-0.168; 
R2 =0.985. The CL method and the long version of PLM cannot be reliably used 
for  DCX+ cells due to their active tangential migration (see text).  Scale bars 25 
μm. 
 
Fig. 5. Ascl1+ cells divide 3 to 4 times before differentiating into 
neuroblasts. A) Experimental outline: C57/BL6 or hGFAP::GFP mice received 
one injection of CldU at t=0 and were analyzed at different time points (n=3). (B) 
Numbers of CldU+, Ascl1+CldU+, hGFAP::GFP+CldU+ and DCX+CldU+ 
cells/mm2 over time; analyzed as whole mounts. All CldU+ and Ascl1+CldU+ cells 
increased during the first day as the labeled cells underwent mitosis, then 
numbers remained high for ~3 for all CldU+ cells and for ~1.5 days for the 
Ascl1+CldU+ population.  We analyzed fewer time points for the DCX+CldU+ 
cells, but for this population the highest value was observed 3 days after CldU.  At 
all time points, only a small fraction of all CldU+ cells corresponded to 
hGFAP::GFP+ cells; these cells increased in numbers during the first day, 
remained high for ~2.5 days and decreased gradually at day 4 and 7 (B; 
expanded scale in C). (D) Percentage of each cell type within the CldU-labeled 
population. While labeled Ascl1+ decreased with survival, DCX+CldU+ cells 
sharply increased. (E) Percentage of CldU+ cells in each population. The 
percentage of labeled Ascl1+ cells decreased progressively between 1 and 3 
days while labeled cells within the DCX+ population increased during this period.  
(F-G). Evaluation of the number of times Ascl1+ cells divide. (F) Experimental 
outline: C57/BL6 mice received one injection of CldU at t=0 and one of EdU at 
different time points 30' before sacrifice. CldU+EdU- cells were in S phase at t=0 
while EdU+ cells were in S phase at time of analysis. (G) Ratio of 
Ascl1+CldU+EdU- cells to Ascl1+EdU+ cells varies cyclically according to the cell 
cycle of Ascl+ cells and revealed three troughs (arrows, corresponding to one cell 
cycle) approximately one day apart.  
 
Fig. 6. Inferred Lineage and cell cycle parameters for V-SVZ progenitor 
cells. Data suggest that after the initial division of GFAP+ B1 cells, Ascl1+ C cells 
divide three times, and A cells once (possibly twice).  Assuming no cell death the 
asymmetric division of one B1 cell results in the generation of 16 (32) A cells; see 
Discussion for other assumptions and limitations of the analysis. (A) Right: 
illustration of the V-SVZ lineage indicating amplification steps from a B1 cell (blue) 
through C cells (green) to A cells (red). Grey arrows: divisions; red arrows: 
differentiation. Left: The calculated TC, TS, TG1 and percent of proliferating cells 
(GF of B1 & C cells from CLM; percent of Ki67-labeled for A cells). (B) Graphical 
representation of the cell cycle phases in B1, C and A cells.  For B1 cells, the 
length of TG2 and TM is approximate (~) given the low numbers of mitotic (pHH3+) 
B1 cells present (see Fig S1W). 
 
32 
Supplementary material 
Fig. S1. (A)  Diagram of the whole mount  of the lateral (up) and medial (down) 
walls of the lateral ventricles used to quantify cell cycle dynamics in the V-SVZ; 
subregions used for counting: AD, anterior dorsal, AV anterior ventral, PD 
posterior dorsal, PV posterior ventral of the lateral wall and MV ventral part of the 
medial wall.   
(B-I) EdU is toxic to cells attempting a second S phase. Comparison of the 
number of labeled cells at different survivals following a single 50 mg/kg injection 
of EdU (B-D) or CldU (E-G). (B) Experimental outline: mice received EdU and 
were analyzed at different time points. (C) Confocal analysis of labeling for EdU in 
mice analyzed 30’ after injection:  EdU labeled cells display nuclear staining; 
pyknotic nuclei were extremely rare. (D)  Confocal analysis of labeling for EdU in 
mice analyzed 24 hrs after injection showing many pyknotic EdU-labeled cells 
(arrows). (E) Experimental outline: mice received CldU and were analyzed as 
above for EdU. (F)  Confocal analysis of labeling for CldU in mice treated 30’ after 
the injection: the number of labeled cells is similar to the number of labeled cells 
in mice treated with EdU (above). (G)  Confocal analysis of labeling for CldU 24 
hrs after injection;  the number of CldU-labeled cells is higher than EdU-labeled 
cells at this survival and unlike EdU, pyknotic nuclei were rare. (H-I) Quantification 
of the number of cells that incorporated EdU or CldU at different intervals after 
injection. (H) For time points shorter than 36 hrs, the number of labeled cells in 
animals treated with EdU was similar to the number of labeled cells in animals 
treated with CldU.  However, at longer time points the number of EdU+ cells was 
lower than the number of CldU + cells. (I) Quantification of the number of Ascl1+ 
cells double labeled with the thymidine analogs. The number of double labeled 
Ascl1+ EdU+ cells was similar to the number of Ascl1+ CldU+ cells at short 
survivals but is lower one day or more after the thymidine analog injection. Means 
(n=3) ± SEM. 
(J-V) Aldh1 and GLAST expression in V-SVZ cell types. (J-O)  Aldh1::GFP 
reporter mice. GFP was expressed in GFAP+ cells (J) and labeled the apical 
processes of B1 cells in pinwheels (K; β-catenin delineated the apical cell 
membranes of ependymal cells and B1 cells; γ-tubulin labeled basal bodies of 
cilia). (L, M) Some S100β+ ependymal cells (16.78+/-3.50%) expressed GFP. (N, 
O)  Only few GFP+ cells co-expressed Ascl1+ (4.20+/-2.39%). (P-V)  
GLAST::DsRed reporter mice. DsRed was expressed in GFAP+ cells (P) and 
labeled the apical processes of B1 cells in pinwheels (Q). (R) DsRed was not 
expressed in S100β+ ependymal cells. (S-U) DsRed was expressed in Ascl1+ C 
cells (7.32+/-0.68% DsRed+ cells were Ascl1+ (T); 8.29+/-1.06% of Ascl1+ cells 
were DsRed+ (U). (V)  DsRed was retained also in some DCX+ A cells. Scale 
bars 10 μm 
(W)  PLM of hGFAP::GFP cells. Following a single injection of CldU, the number 
of mitotic (pHH3+) CldU+ B1 cells (hGFAP::GFP) increased from 0% at 30’ to 
100% at 6 hrs. Ratio of triple labeled cells (GFP+pHH3+CldU+) to mitotic 
(GFP+pHH3+) cells resulted in  TG2 of at least 30’ and TG2+TM of 6hrs.  
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FigS2 (A-E) Proliferation rate in the V-SVZ is not influenced by circadian rhythm.  
(A)  Experimental outline: mice received a single EdU injection at different times 
of the day and night and were analyzed 30’ later.  (B-C) At different times of the 
day we observed similar numbers of EdU + (B) or pHH3+ cells.  (D-E)  Similarly, 
the number of double labeled pHH3+ hGFAP::GFP+ (D) or Ascl1+ (E) cells was 
similar at the different times of day.  However, there was a slight but non-
significant increase in the number of mitotic GFP+ cells just before midnight (D). 
Means (n=3) ± SEM.  
 (C) Ascl1+ cells have similar cell cycle dynamics in C57/BL6 and hGFAP::GFP 
mice. Comparison of the cell cycle dynamics of Ascl+ cells in C57/BL6 and 
hGFAP::GFP mice (CL method; for experimental outline see Fig.  3A).   
(G-J)  The cell cycle and S phase length for Ascl1+ cells are similar in different  
V-SVZ subregions. Cell cycle (CL; G, I) and S phase length (PLM; H, J) of Ascl1+ 
cells in ventral vs. dorsal (G, H) and anterior vs. posterior (I, J) V-SVZ. Cell cycle 
dynamics were remarkably similar in ventral and dorsal and comparable between 
the anterior and posterior V-SVZ with a slightly longer TC in the posterior 
subregion (K) Comparison of the length of all cell cycle phases (columns) 
determined with the three different approaches used in different V-SVZ 
subregions (rows, V; ventral, D; dorsal, A; anterior, P; posterior, also see Figs. 
S1E & S2GJ). 
 
